On 'cognitive dysfunction' as a novel target for antidepressant treatment.

about

On 'cognitive dysfunction' as a novel target for antidepressant treatment.

Item

http://www.wikidata.org/entity/Q44299752

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

On 'cognitive dysfunction' as a novel target for antidepressant treatment.

@en

On 'cognitive dysfunction' as a novel target for antidepressant treatment.

@nl

type

Item

label

On 'cognitive dysfunction' as a novel target for antidepressant treatment.

@en

On 'cognitive dysfunction' as a novel target for antidepressant treatment.

@nl

prefLabel

On 'cognitive dysfunction' as a novel target for antidepressant treatment.

@en

On 'cognitive dysfunction' as a novel target for antidepressant treatment.

@nl

P1476

On 'cognitive dysfunction' as a novel target for antidepressant treatment.

@en

P2093

Bethan Impey

http://www.w3.org/2001/XMLSchema#string

David S Baldwin

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of cognitive remediation in schizophrenia

“Mini-mental state”

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.

Personalized cognitive training in unipolar and bipolar disorder: a study of cognitive functioning

A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression.

A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder.

Cognitive impairment in euthymic major depressive disorder: a meta-analysis.

Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.

Acute administration of citalopram facilitates memory consolidation in healthy volunteers.

Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.

P304

535-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/HUP.2360

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24519689

http://www.w3.org/2001/XMLSchema#string